Avitas Wealth Management LLC Abb Vie Inc. Transaction History

Avitas Wealth Management LLC

$674 Million
Q2 2024

A detailed history of Avitas Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Avitas Wealth Management LLC holds 24,356 shares of ABBV stock, worth $4.73 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

24,356

Previous 24,601 1.0%

Holding current value

$4.73 Million

Previous $4.48 Million 6.74%

% of portfolio

0.62%

Previous 0.69%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$154.79 - $180.76 $37,923 - $44,286	-245 Reduced 1.0%	24,356 $4.18 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $7,191 - $8,194	-45 Reduced 0.18%	24,601 $4.48 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $64,396 - $72,525	468 Added 1.94%	24,646 $3.82 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $1.29 Million - $1.49 Million	-9,645 Reduced 28.52%	24,178 $3.6 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $51,678 - $64,311	-390 Reduced 1.14%	33,823 $4.56 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $59,723 - $68,781	-413 Reduced 1.19%	34,213 $5.45 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $960,562 - $1.15 Million	6,945 Added 25.09%	34,626 $0
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $47,644 - $54,645	355 Added 1.3%	27,681 $3.72 Million
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $1.02 Million - $1.3 Million	7,443 Added 37.43%	27,326 $4.19 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $2.62 Million - $3.26 Million	19,883 New	19,883 $3.22 Million
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $2.18 Million - $2.62 Million	-34,579 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $765,405 - $978,367	11,650 Added 50.81%	34,579 $2.52 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $40,652 - $47,846	-527 Reduced 2.25%	22,929 $1.85 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $524,631 - $647,011	6,739 Added 40.31%	23,456 $2.16 Million
Q3 2018 Dec 19, 2018	SELL	$88.91 - $98.84 $17,782 - $19,768	-200 Reduced 1.18%	16,717 $1.58 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $31,118 - $34,594	350 Added 2.11%	16,917 $1.6 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $1.49 Million - $1.76 Million	16,567 New	16,567 $1.54 Million

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.

Account

Avitas Wealth Management LLC Abb Vie Inc. Transaction History